Read + Share
Amedeo Smart
Independent Medical Education
Yi C, Chen L, Ling Z, Liu L, et al. Lenvatinib Targets FGFR4 to Enhance Antitumor Immune Response of Anti-PD-1 in Hepatocellular Carcinoma. Hepatology 2021 May 26. doi: 10.1002/hep.31921.PMID: 34036623
Email
LinkedIn
Facebook
Twitter
Privacy Policy